Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Preliminary 2012 portfolio & SP investment update

11 Jul 2012 07:00

RNS Number : 3809H
CATCo Reinsurance Opps Fund Ltd
11 July 2012
 



CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

Preliminary 2012 portfolio and side pocket investment update

 

To: SFM, London Stock Exchange and the Bermuda Stock Exchange

Date: 11 July 2012

 

The Company's Ordinary Shareholders are indirectly exposed to potential losses arising from the New Zealand earthquake that occurred on 22 February 2011 and the Japan earthquake that occurred on 11 March 2011 (respectively, the "NZ Exposure" and the "Japan Exposure") through the Company's investment in CATCo Reinsurance Fund Ltd - Diversified Fund (the "Master Fund") and ultimately through CATCo-Re Ltd. ("CATCo-Re").

 

The Company's C Shareholders are not exposed to the NZ or Japan Exposures and do not participate in any losses or premiums attributable thereto.

 

The Company's investment manager, CATCo Investment Management Ltd (the "Investment Manager"), has recently held meetings with the two retrocessional reinsurance counterparties (the "Reinsurance Counterparties") that represent the NZ and Japan Exposures and has been informed that both Reinsurance Counterparties have implemented a 100% loss reserve on their respective balance sheets associated with CATCo-Re's protections. As a consequence, the Master Fund's Board of Directors has resolved to include the same loss reserve provision in the Net Asset Value calculation as at 30 June 2012, which will, in turn, be reflected in the Company's Net Asset Value.

 

Shareholders should note that this is a loss reserve, and not a crystalised loss, as CATCo-Re's protections are based on the actual paid claims. Based on the most recent loss advice, one Reinsurance Counterparty, representing 31.4% of the Japan Exposure, has been fully paid by CATCo-Re, so this loss is settled with them. This Reinsurance Counterparty also represents 100% of the NZ Exposure, but, to date, has not sought any loss payment from CATCo-Re related to this. The other Reinsurance Counterparty, representing 68.6% of the Japan Exposure, has not sought any loss payment from CATCo-Re to date.

 

The Investment Manager has recently sought to commute the NZ and Japan Exposures once the Reinsurance Counterparties' loss reserves were better known. However, the proposals were rejected by the Reinsurance Counterparties due to the expected size of their respective reinsurance loss reserves.

 

Over the past 15 months, the Investment Manager has attended numerous meetings with the Reinsurance Counterparties and, in January 2012, CATCo-Re had implemented loss reserves representing 100% of the NZ Exposure and 30% of the Japan Exposure. The lower reserve level on the Japan Exposure was driven by the fact that CATCo-Re had specific retrocessional protections in place at the time of the Japan earthquake. According to the Reinsurance Counterparty representing 68.6% of the Japan Exposure, these protections were expected to shield CATCo-Re from any losses in relation to Japan. However, this Reinsurance Counterparty has now significantly increased their Japan earthquake loss reserves. Prior to the most recent loss advice from this Reinsurance Counterparty, it had always been suggested that the insurance reserves being held were well below those detailed in loss event deductibles set out in the relevant Reinsurance Agreements. As such, the Investment Manager had maintained the opinion, based on discussions with the Reinsurance Counterparty, that it did not believe that there were any potential losses related to this counterparty's Japan Exposure. However, the earthquake and tsunami losses in the Tohoku region of Japan last year have continued to escalate.

 

For illustrative purposes only, had the 100% loss reserve been put in place at 31 December 2011 this would have equated to a NAV per Ordinary Share of $0.8950.

 

The Board of Directors is currently assessing the most efficient manner by which to merge the C Shares, which have no exposure to the NZ and Japanese Exposures, with the Ordinary Shares.

 

 

-Ends-

 

For further information, please contact:

 

Jason Bibb, Director

CATCo Investment Management Ltd

Telephone: +1 441 531 2227

Email: jason.bibb@catcoim.com 

 

David Benda / Hugh Jonathan

Numis Securities Limited

Telephone: +44 (0)20 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEXFFESAEEF
Date   Source Headline
18th Dec 20241:48 pmRNSResult of Meeting
18th Dec 20247:30 amRNSSuspension - CATCo Reinsurance Opps Fund Ltd
18th Dec 20247:00 amRNS3rd Quarter Results
22nd Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
18th Nov 20247:00 amRNSCirc re. Proposed winding up and notice of SGM
13th Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
29th Oct 20247:00 amRNSNet Asset Value(s)
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
27th Sep 20243:05 pmRNSHalf-year Report
4th Sep 20247:00 amRNSNet Asset Value(s)
10th Jun 20247:00 amRNSNet Asset Value(s)
5th Jun 20242:21 pmRNSResult of AGM
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.